Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease.

about

Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.Modeling analysis of the relationship between atherosclerosis and related inflammatory factors.

P2860

Q49220874-8D1655DF-066D-44BE-8CB2-80898C185BEA Q52382250-6F7384FD-2EE0-4F78-BED4-33DF6173ADB6

P2860

Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease.

Item

http://www.wikidata.org/entity/Q40983126

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Lipoprotein(a) as a predictor ...... stable coronary heart disease.

@en

type

Item

label

Lipoprotein(a) as a predictor ...... stable coronary heart disease.

@en

prefLabel

Lipoprotein(a) as a predictor ...... stable coronary heart disease.

@en

P1476

Lipoprotein(a) as a predictor ...... stable coronary heart disease.

@en

P2093

F Guo

http://www.w3.org/2001/XMLSchema#string

H Xia

http://www.w3.org/2001/XMLSchema#string

J-S Hu

http://www.w3.org/2001/XMLSchema#string

Y Fan

http://www.w3.org/2001/XMLSchema#string

Z-B Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease.

Coronary microcirculation: physiology and pharmacology.

Collateralization and the response to obstruction of epicardial coronary arteries.

Recent insights into human coronary collateral development.

Clinical contribution of the collateral circulation to myocardial protection.

Assessment of the human coronary collateral circulation.

Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease.

Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction.

High lipoprotein(a) levels and small apolipoprotein(a) sizes are associated with endothelial dysfunction in a multiethnic cohort.

Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene.

P304

e5979

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/1414-431X20175979

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28700032

http://www.w3.org/2001/XMLSchema#string

P921

LPA

lipoprotein

P932

5505520

http://www.w3.org/2001/XMLSchema#string

Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease.

about

P2860

P2860

Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932